Ancrod

N/A

Report date: 2023/11/01 20:08:59

Base Information

Drug NameAncrod
Drug Alias NameNM-VViprinex
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Toxin
Mechanisms of ActionFibrinogen inhibitors
TargetsFibrinogen
Therapy Area/IndicationsStrokeBrain InfarctionBrain Ischemia +[8
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[16
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsStrokeBrain InfarctionBrain Ischemia +[8

Other Information

ATC CodeB01AD09
Related LinksN/A